Varifarma Peru and Myriad Genetics on a new agreement
February 14, 2020
Within the framework of our continuous commitment to patients in the Latin American region, we are pleased to announce the new agreement of Varifarma Peru with Myriad Genetics for the quantity of its products in the country.
Among them we find Endopredict®️ and Prolaris®️, two state-of-the-art genomic tests used in the diagnosis and treatment of Breast Cancer and Prostate Cancer, respectively.
